PRIMARY Ancillary Substudy
NCT: NCT07103733 · ACTIVE_NOT_RECRUITING
Brief Summary
The PRIMARY trial (NCT05051033), which compares mitral valve repair (MVr) to transcatheter-edge-to-edge-repair (TEER), offers a platform for conducting mechanistic studies to develop early insights into the pathophysiological processes by which mitral valve prolapse (MVP) can impact left ventricular (LV) myocardial structure and function, and, thereby, predispose to arrhythmias and sudden death. Such insights are key to identifying interventions to reduce the long-term sequelae of heart failure (HF) and arrhythmias, as well as delineate optimal therapeutic approaches for different patient sub-groups.
Frequently Asked Questions
What is PRIMARY Ancillary Substudy?
PRIMARY Ancillary Substudy is a clinical trial registered under NCT07103733. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07103733?
The current status of NCT07103733 (PRIMARY Ancillary Substudy) is: ACTIVE_NOT_RECRUITING.
When did PRIMARY Ancillary Substudy start?
PRIMARY Ancillary Substudy started on 2023-10-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.